5-Amino-1MQ: Mechanism of Action

1. Primary Target — NNMT Enzyme

The molecular target of 5-Amino 1MQ e o(a) cytosolic enzyme nicotinamide N-methyltransferase (NNMT), a metabolic regulator highly expresso(a) em tecido adiposo, liver, and musculo esqueletico — particularmente in obesidade and diabetes tipo 2. [2]

Binding Mechanism: 5-Amino 1MQ is a substrate-competitive inhibitor. It competes with nicotinamide (NAM) para o(a) ativo(a) binding site of NNMT, preventing a enzima from catalyzing the transfer of a methyl group from SAM to NAM. This blockade previne formation of 1-methylnicotinamide (1-MNA) and S-adenosyl-L-homocysteine (SAH). [3]

Potency:

• IC₅₀: ~1.0–1.2 µM for NNMT inibicao [1]
• EC₅₀: 2.3 ± 1.1 µM (reduction of intracellular 1-MNA levels) [1]
• Lipogenesis Inhibition: 30 µM reduziu lipogenesis by 50%; 60 µM by 70%

2. Downstream Cascade A — NAD+ Salvage and SIRT1 Activation

NNMT normally acts como um(a) “sink” for nicotinamide, permanently removing it do(a) NAD+ salvage pathway by methylating it into 1-MNA (which is then excreted). By inhibiting NNMT, 5-Amino 1MQ preserva the intracellular NAM pool, shunting it back no(a) NAD+ salvage pathway and significantly increasing intracellular NAD+ levels. [4]

Elevated NAD+ acts como um(a) co-substrate for sirtuins, specifically activating SIRT1 — often called the “longevity gene.” SIRT1 ativacao drives aumentou biogenese mitocondrial and metabolic rate. [8]

3. Downstream Cascade B — Methionine-SAM Cycle and Epigenetic Regulation

NNMT consumes SAM (the universal methyl donor) during NAM metilacao. 5-Amino 1MQ previne this consumption, increasing intracellular SAM levels and reducing SAH (a metilacao inhibitor). This alters the cell’s epigenetic metilacao potential, influencing histone and DNA metilacao states que regulate expressao genica for adipogenesis and metabolismo. [4] [9]

4. Downstream Cascade C — Exercise Mimicry (Muscle-Specific)

In musculo esqueletico, 5-Amino 1MQ desencadeia unique signaling: [10]

• Ribosomal Biogenesis: Upregula proteins envolveu in ribosomal RNA biogenesis and aminoacyl-tRNA ligase activity, mimicking a proteina traducao signaling normally induzido(a) por exercise.
• Transsulfuration Pathway: Unicamente upregula the transsulfuration pathway (via cystathionine β-synthase), enhancing protection against reactive oxygen species (ROS) via glutathione synthesis.
• AMPK Activation: Shifts the metabolome of sedentary muscle toward an exercised state via aumentou AMP, driving AMPK ativacao — um(a) critico(a) energy sensor promoting muscle hypertrophy and protein traducao.

5. Receptor Selectivity

5-Amino 1MQ demonstra high selectivity for NNMT, avoiding off-target effects: [3]

• Does NOT inhibit structurally related SAM-dependent methyltransferases: DNMT1, PRMT3, COMT
• Does NOT inhibit NAD+ pathway enzymes: NAMPT, SIRT1

This confirma que NAD+ and SAM aumenta result solely from preventing their degradacao by NNMT, not from interfering with their synthesis or utilization enzymes.

6. Cellular and Tissue-Level Effects

Adipose Tissue (White Fat):

• Suppresses lipogenesis (fat creation) in adipocitos [1]
• Reduces white adipocito size by >30% and WAT mass by ~35% [2]
• Produces um(a) unico(a) metabolomic signature (aumentou ketogenic aminoacidos)
• No alteration in food intake [2]

Skeletal Muscle:

• Activates senescent muscle celulas-tronco (MuSCs), promoting proliferacao and myofiber repair [11]
• Nearly 2-fold increase in myofiber cross-sectional area; ~70% increase in peak torque
• Sustained running capacity sem fatigue taper [10]

Liver:

• Reverses hepatico(a) steatosis (fatty liver) and normalizes ALT/AST [12]
• Reduces total plasma cholesterol by ~30% [2]

7. Pharmacokinetics

Parameter	Rat (Oral)	Rat (IV)
Oral Bioavailability	38.4%	—
Half-Life (T½)	6.9 ± 1.2 h	3.8 ± 1.1 h
Cmax	2,252 ng/mL	—
Membrane Permeability	High (passive + ativo(a) transport)
Tissue Distribution	Adipose, muscle, liver; no 24h accumulation in heart/kidney/brain

Source: Awosemo/Neelakantan et al., J. Pharm. Biomed. Anal., 2021 [7]